The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current Evidence

Patients with inflammatory bowel disease, psoriasis or other rheumatic diseases treated with corticosteroids, immunomodulators and biologics might face additional risk during COVID-19 epidemic due to their immunocompromised status. However, there was still no unanimous opinion on the use of these th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mengyuan, Bai, Xiaoyin, Cao, Wei, Ji, Junyi, Wang, Luo, Yang, Yang, Yang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317986/
https://www.ncbi.nlm.nih.gov/pubmed/34335579
http://dx.doi.org/10.3389/fimmu.2021.677957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317986/
https://www.ncbi.nlm.nih.gov/pubmed/34335579
http://dx.doi.org/10.3389/fimmu.2021.677957

Ejemplares similares